AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
13 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
12 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
11 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
08 Apr 2011 04:30 PM
RNS
Annual Information Update
08 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
07 Apr 2011 07:00 AM
RNS
FDA Approval for Vandetanib
07 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
06 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
05 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
04 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
01 Apr 2011 04:00 PM
RNS
Total Voting Rights
01 Apr 2011 07:00 AM
RNS
Transaction in Own Shares
31 Mar 2011 05:30 PM
RNS
Director/PDMR Shareholding
31 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
30 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 05:45 PM
RNS
Director/PDMR Shareholding
29 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
28 Mar 2011 08:00 AM
RNS
UK and US reach agreement over tax matters
28 Mar 2011 08:00 AM
RNS
Transaction in Own Shares
28 Mar 2011 07:00 AM
RNS
UK and US reach agreement over tax matters
28 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
25 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
24 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
23 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
22 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
21 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
18 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
17 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
16 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
15 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
14 Mar 2011 01:30 PM
RNS
Directorate Change
14 Mar 2011 01:30 PM
RNS
Annual Financial Report
14 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
11 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
10 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
09 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
08 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
07 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
04 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
03 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
02 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
01 Mar 2011 03:00 PM
RNS
Total Voting Rights
01 Mar 2011 07:00 AM
RNS
Transaction in Own Shares
28 Feb 2011 04:00 PM
RNS
Director/PDMR Shareholding
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100